Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Learn more about the possibilities of this page
Latest predictions
-
30.10.20
buy
-
08.09.20
-
31.05.20
buy
€94.00
18.06.19
buy
€67.65
16.01.19
buy
€64.94
09.09.18
buy
Your prediction

Agilent Technologies Inc. Stock

There is nearly no change for the Agilent Technologies Inc. stock today. Compared to yesterday it only changed by -€0.310.
Currently there is a rather positive sentiment for Agilent Technologies Inc. with 5 Buy predictions and 1 Sell predictions.
However, we have a potential of -1.468% for Agilent Technologies Inc. as the target price of €94.00 is below the current price of €95.40.

Pros and Cons of Agilent Technologies Inc. in the next few years

Pros
1
Future proof or reliable business model
1
Known brand
1
Market Leader or Top 3
1
Higher EBIT margin than peer group
Cons
0
-

Comments

Buy Agilent Technologies Inc.

Sell Agilent Technologies Inc.

Published 10.12.19
Prediction Buy
Perf. (%) 21.61%
Target price 125.000
Change

Buy with target price 125.0

Show more
Not a member yet? Sign up for free!

Other discussions about Agilent Technologies Inc. Stock

Trading Agilent Technologies Inc.

Trading Agilent Technologies Inc.

New thread Forum

News

Agilent Reports Fourth-Quarter and Fiscal Year 2020 Financial Results; Initiates Fiscal 2021 Guidance: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24221/330px-Agilent.svg.png
Agilent Reports Fourth-Quarter and Fiscal Year 2020 Financial Results; Initiates Fiscal 2021 Guidance


Agilent Technologies Inc. (NYSE: A) today reported revenue of $1.48 billion for the fourth quarter ended Oct. 31, 2020, up 8% year over year (core(1) growth of 6%).



On a GAAP basis

Agilent Launches New NanoDis System for Nanoparticle Dissolution Testing: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24221/330px-Agilent.svg.png
Agilent Launches New NanoDis System for Nanoparticle Dissolution Testing


Agilent Technologies Inc. (NYSE: A) today announced the introduction of the NanoDis System for nanoparticle dissolution testing. Combining Agilent instrumentation and software to enable customers

Agilent Increases Cash Dividend to 19.4 Cents Per Share: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24221/330px-Agilent.svg.png
Agilent Increases Cash Dividend to 19.4 Cents Per Share


Agilent Technologies, Inc. (NYSE: A) today announced that its board of directors has increased the company’s quarterly dividend to 19.4 cents per share of common stock. The dividend reflects an 8%

Agilent Presents Thought Leader Award to Drs. Carl H. June and Michael Milone: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24221/330px-Agilent.svg.png
Agilent Presents Thought Leader Award to Drs. Carl H. June and Michael Milone


Agilent Technologies Inc. (NYSE: A) today announced professors Carl H. June, MD, and Michael Milone, MD, Ph.D., as recipients of an Agilent Thought Leader Award. Both scientists are being

Agilent Receives Expanded FDA Approval for PD-L1 IHC 22C3 pharmDx in Triple-Negative Breast Cancer : http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24221/330px-Agilent.svg.png
Agilent Receives Expanded FDA Approval for PD-L1 IHC 22C3 pharmDx in Triple-Negative Breast Cancer


Agilent Technologies Inc. (NYSE: A) today announced it has received FDA approval for the use of PD-L1 IHC 22C3 pharmDx as an aid in identifying patients with triple-negative breast cancer (TNBC)

Agilent Collaborates With SGS to Release New US EPA Method for the Analysis of Dioxins Using GC/TQ: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24221/330px-Agilent.svg.png
Agilent Collaborates With SGS to Release New US EPA Method for the Analysis of Dioxins Using GC/TQ


Agilent Technologies Inc. (NYSE: A) announced today a collaboration with SGS has resulted in a new GC/TQ method, the SGS AXYS Method 16130, approved by the US EPA as an alternative method for the

Agilent to Webcast Fourth-Quarter Fiscal Year 2020 Financial Results Presentation, Sets Date for Virtual Analyst and Investor Meeting: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24221/330px-Agilent.svg.png
Agilent to Webcast Fourth-Quarter Fiscal Year 2020 Financial Results Presentation, Sets Date for Virtual Analyst and Investor Meeting


Agilent Technologies Inc. (NYSE: A) will release fourth-quarter fiscal year 2020 financial results after the stock market closes on Monday, Nov. 23. The company will host a live webcast of its

Agilent to Showcase Their Commitment to Sustainability at analytica virtual 2020: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24221/330px-Agilent.svg.png
Agilent to Showcase Their Commitment to Sustainability at analytica virtual 2020


Agilent Technologies Inc. (NYSE: A) today announced that their 1220, 1260, and 1290 Infinity II LC product families have received the My Green Lab accountability, consistency, and transparency

Agilent Vaya Raman Raw Material ID Verification System Receives 2020 R&D 100 Award: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24221/330px-Agilent.svg.png
Agilent Vaya Raman Raw Material ID Verification System Receives 2020 R&D 100 Award


Agilent Technologies Inc. (NYSE: A) today announced that the Agilent Vaya Raman raw material identity verification system has received a 2020 R&D 100 Award in the Analytical/Test category. The

Agilent Early Career Professor Award Presented to Carl DeSelm: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24221/330px-Agilent.svg.png
Agilent Early Career Professor Award Presented to Carl DeSelm


Agilent Technologies Inc. (NYSE: A) today announced that Carl DeSelm, M.D., Ph.D., has received the 2020 Agilent Early Career Professor Award. Dr. DeSelm is an assistant professor of Radiation

Agilent Announces the Availability of Objective Decision Support for Pathologists Reviewing Breast Cancer Cases: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24221/330px-Agilent.svg.png
Agilent Announces the Availability of Objective Decision Support for Pathologists Reviewing Breast Cancer Cases


Agilent Technologies Inc. (NYSE: A) today announced the expansion of Visiopharm’s validated image analysis algorithm to incorporate HercepTest™ mAb pharmDx for Dako Omnis, both CE-IVD marked and

Agilent Expands Line of Innovative Flow Cytometers with the NovoCyte Penteon


Agilent Technologies Inc. (NYSE: A) today announced the launch of the Agilent NovoCyte Penteon, a sensitive flow cytometer with five lasers and up to 30 fluorescence channels. The NovoCyte Penteon

Agilent Announces Cash Dividend of 18 Cents Per Share


Agilent Technologies Inc. (NYSE: A) today announced that a quarterly dividend of 18 cents per share of common stock will be paid on Oct. 28, 2020, to all shareholders of record as of the close of

Agilent Announces Webcast for Investment Community


Agilent Technologies Inc. (NYSE: A) today announced the company will participate in the Wells Fargo 2020 Virtual Healthcare Conference on Wednesday, Sept. 9. A webcast of the event will be

Agilent Announces SureSelect XT HS2 RNA Reagent Kit, a Library Prep and Target Enrichment Solution for RNA-Seq


Agilent Technologies Inc. (NYSE: A) today announced the release of the SureSelect XT HS2 RNA Reagent Kit. This solution features a modular design that enables a simple and parallel approach for

Agilent Sets the Standard in Customer Flexibility with Analytical Technology Subscription Model


Agilent Technologies Inc. (NYSE: A) today announced its first-ever instrument subscription program, designed to meet the needs of customers with dynamic businesses who want the latest technology

Agilent Reports Third-Quarter Fiscal Year 2020 Financial Results


Agilent Technologies Inc. (NYSE: A) today reported revenue of $1.26 billion for the third quarter ended July 31, 2020, a decline of 1% compared to the third quarter of 2019 and down 3.1% on a core(

Agilent to Expand State-of-the-Art Manufacturing Capacity for Nucleic Acid-Based Therapeutics


Agilent Technologies Inc. (NYSE: A) today announced it will expand its state-of-the-art production facility in Frederick, Colorado, that develops and manufactures “oligos,” which are short DNA and

Agilent to Webcast Third-Quarter Fiscal Year 2020 Financial Results Conference Call


Agilent Technologies Inc. (NYSE: A) will release third-quarter fiscal year 2020 financial results after the stock market closes on Aug. 18. The company will also host a live webcast of its investor

Agilent Technologies Announces Pricing of $500 Million of Senior Notes


Agilent Technologies, Inc. (NYSE: A) today announced the pricing of an underwritten, registered public offering of a series of its senior notes in an aggregate principal amount of $500 million. The

Agilent Technologies Announces Proposed Offering of Senior Notes


Agilent Technologies Inc. (NYSE:A) today announced it is offering, subject to market and other conditions, a series of senior notes under an automatic shelf registration statement on file with the